|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00673 CHINA HEALTH
Nominal 
0.670 0.000 (0.000%) | 2025/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/03 HKD(K$) | 2024/03 HKD(K$) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | |
| Turnover | 19,610 | 4.979% | 38,943 | 59,930 | 76,414 | 107,025 |
| Cost of Sales | (17,763) | 6.448% | (29,708) | (46,292) | (49,222) | (78,336) |
| Gross Profit | 1,847 | -7.326% | 9,235 | 13,638 | 27,192 | 28,689 |
| 2025/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/03 HKD(K$) | 2024/03 HKD(K$) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | (17,642) | (18,435) | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | (4,000) | 0 | |
| Profit / (Loss) before Taxation | (10,889) | -38.155% | (67,378) | (42,294) | (39,383) | (8,709) | |
| Taxation | 50 | -- | (443) | (203) | (177) | (405) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 476 | 100.844% | 31 | 2,310 | (2,486) | (3,091) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (10,363) | -40.398% | (67,790) | (40,187) | (42,046) | (12,205) | |
| 2025/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/03 HKD(K$) | 2024/03 HKD(K$) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | |
| Net Finance Costs / (Income) | 532 | -- | 243 | (593) | 1,754 | (40) |
| Depreciation & Amortisation | 708 | -25.000% | 3,412 | 4,548 | 4,152 | 4,031 |
| Directors' Emoluments | -- | -- | 4,040 | 3,236 | 3,251 | 4,240 |
| 2025/09 - Interim | %Chg (Compare to Interim) | 2025/03 | 2024/03 | 2023/03 | 2022/03 | |
| Auditor's Opinion Status | N/A | -- | Disclaimer | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/09 - Interim | %Chg (Compare to Interim) | 2025/03 | 2024/03 | 2023/03 | 2022/03 | |
| EPS (cts) | -2.110 | -26.609% | -11.140 | -6.767 | -7.896 | -2.370 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.014) | (0.013) | (0.046) | 0.077 |
| NBV per share ($) | (0.036) | -- | (0.012) | 0.087 | 0.144341 | 0.145171 |
| Remarks: | Real time quote last updated: 12/12/2025 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -10,363 |
| %Change | -40.398% |
| EPS / (LPS) | HKD -0.021 |
| NBV Per Share ($) | HKD -0.036 |